Search for: "Zabel v. State" Results 41 - 51 of 51
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 May 2021, 6:07 am
Goldstein, Schulte Roth & Zabel LLP, on Tuesday, May 11, 2021 Tags: Beneficial owners, Corporate Transparency Act, Disclosure, Financial regulation, FinCEN, LLCs, Securities enforcement, Securities regulation, Transparency When a Company Takes a Stand, What is the Board’s Role? [read post]
23 Apr 2018, 8:28 am by Dan Carvajal
Key Findings Property tax limitations have been adopted in forty-six states and the District of Columbia, though their designs and restrictiveness differ widely. [read post]
10 Mar 2015, 6:58 am by Joy Waltemath
The magistrate also recommended denying summary judgment on the issues of punitive damages and backpay (Zabell v. [read post]
3 Apr 2012, 1:00 pm by Benjamin Wittes
Earlier today, I had the pleasure of visiting Professor Jack Goldsmith’s “Foreign Relations Law” class, which is studying Hamdan v. [read post]
17 Oct 2021, 2:17 pm by admin
Zabell, Professor of Statistics and Mathematics, Weinberg College of Arts and Sciences, Northwestern University Joe S. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]